Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Just for you Moni.
Grab a coffee, relax. Get a pen a paper (for notes) and research the chap on the right. He knows a thing or two. A tad more than Greta, Al Gore or Bill Gates I would wager.
https://www.youtube.com/watch?v=KhCKYvETYDc
Sorry for the off-topic. I am attempting got save a soul. :)
Moni,
Life is good, even sweat when it is almost taken.
BTW, can you explain your obsessive blathering about global warming and how you arrived at the notion I deny it?
For clarity, and perhaps your sanity, given its fragile nature - I have never denied climate change; it's what the climate does. But wait, don't get too excited; I refuse to believe mankind will be wiped out unless we stop using fossil fuels, and stop cows farting, as we all zip our mouths up and place a peg over our noses, though I see the merits in this for some.
Relax and live as you wish, and stop allowing elitists to influence your every move, especially until they do as they preach.
Why are eco-cultists so illiberal people?
Farris,
Positive results from Acne and Oral will put the SBTX board in a very good heart. It will almost certainly be encouraging for a prospective partner looking to add a natural alternative to a well-being product portfolio within skin and oral care. The SBTX partnership with an MN becomes more attractive for all parties. The ideal partner previously named could strike a deal for Psoriasis, Acne and Oral care - they fit very well inside their portfolio of products in the well-being segments. It would be a highly significant win for SBTX; both probiotics could be commercially viable quickly after the Acne study results, and a natural oral option would be a little further down the regulatory road but still quite speedy compared to existing products because of the natural nature of the IP.
Stuart stated in his interview with TW: ACNE TIMELINE and Posible MN deal - "Answer your question, timeline. I would love to get the deal over the line this calendar year before Christmas will be the best Christmas present for everyone. Is there a chance of that? Yes, there is, but it would require Acne to happen quickly, cleanly, and positively and be successful in its trial.
It appears Oral care results and Acne are due by the end of this month. Very likely to be positive outcomes which should lift the SP higher.
Https://lemminginvestor.substack.com/p/skinbiotherapeutics-plc-c08/comments
In an increasingly complex and dynamic financial landscape, companies that successfully navigate the intersection of technology and responsible investing are poised to stand out. Insig AI’s Final Report announced today showcases its strategic advancements, partnerships, and financial achievements, shedding light on its positioning in this evolving market ESG market hoisted upon us all, whether we like it or not, by Blackrock. There is a, but that is progressing slower and frustrating investors and board members, as you will read. https://twitter.com/LEMMINGINVESTOR/status/1691092985612816384
#POLB analysis has successfully identified p38 MAP Kinase as a severe influenza driver inhibited by POLB 001.
@PoolbegPharma deep-collaboration
https://is.gd/5hfhjG
Ref clinical study. Based on in-house tests during the scale-up processes, this is a necessary formality. The newly discovered "enhancements" confirm this. The clinical study is being conducted independently to support specific claims that can be made in marketing materials for Sederam's clients - it is the marketing literature supported by the clinical study that will rock the industry as it breaks new ground.
It seems that Gary made a mistake when he suggested that SBTX may need to raise money by the end of this year. He probably meant by the end of next year. The Company had over £3 million in cash as of January and their expenses are around £200,000 per month. With studies finishing up this summer, they should be in good shape financially.
Despite concerns from investors for almost a year about OPTI sales, the suppression of buying activity has recently been lifted and he has chosen to ignore these concerns.
Ref; Laura Bey Head of Formulations, recently joined from Unilever.
Aquae, you're a smart fella. I am sure, like me, you are thinking what I am thinking - the identity of the multinational is Unilever. Laura Bey is still at Unilever, which suggests to me at least Laura has been given an oversight seat inside SBTX for a specific purpose. https://lemminginvestor.substack.com/p/skinbiotherapeutics-plc-c08
Simples,
Can you provide more information on why you think that SBTX lacks proven science? The lysate has undergone scientific validation, which is why Croda was eager to make a deal with them.
It may not be wise to rely solely on the peer review process, as not all scientific work undergoes this type of review. Additionally, some individuals feel that the peer review process has been influenced by certain groups and ideologies, leading to a lack of objectivity. As a result, a group of over 12000 scientists have established their own peer review database. However, even with these efforts, there are still instances where individuals with significant influence, such as Bill Gates, are able to remove founding members from the process. The guy is evil.
Watch and learn. https://youtu.be/NtroGK9D6-o
This guy is ok too. https://lemminginvestor.substack.com/
https://www.youtube.com/watch?v=eZsW0tVnpCs
Companies face pressure to disclose net zero credentials in greenwashing crackdown
Climate reporting rules rolled out as ESG investing comes under fire
https://twitter.com/lemminginvestor/status/1687217035393032193?s=46
Farris,
The uncensored thread you speak of has very few people posting. I know of at least 30 plus pseudonyms by one fella, Joseph Sheedy. He is one of my biggest fans. :)
I am sure he is the life and should be on a night out with the boys. :)
Cross-ref them over OPTI, SYME and SBTX if you are bored. There is a glaringly obvious trend that gives him away.
PB,
This funding is a positive development for OPTI as it allows them to maintain their cash reserves in the bank while financing the procurement of raw materials from their manufacturing partners, including Cambridge Commodities and Maxums, to mention a few. OPTI will need to conserve funds for the upcoming SweetBiotix launch, which I anticipate will occur as a soft launch sometime this year. Although a rumour landed in my inbox suggesting it will land this week. God loves a trier ;)
The big question is how quickly OPTI receive royalties from their partners once they have received the prebiotics.
SBTX PI's can now breathe easier knowing that Thors' hammer has been put away for the foreseeable future. This should give them the confidence to stake-build ahead of any news from the company. We are aware that the company has several projects in progress, and we eagerly await news on the Croda project, which is not expected until 2024. In the meantime, we can hope for partnerships in the other four pillars, a possible multi-national partnership for AxisBiotix, or M&A activity, which has been ongoing for about eight months.
So, good news all round.
Clio,
Toyin deserves credit for raising a query about the 1 million sale on 6\6 with TW. He asked SOH, who gave a response that was not very clear, which made me suspicious. SOH has since clarified his plan for raising working capital. When investors asked me a few questions, I decided to share my hypothesis to see if it would spark any insights.